These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 4319737)

  • 1. [Japanese encephalitis vaccine].
    Oya A
    Naika; 1970 Sep; 26(3):494-5. PubMed ID: 4319737
    [No Abstract]   [Full Text] [Related]  

  • 2. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
    Monath TP; Guirakhoo F; Nichols R; Yoksan S; Schrader R; Murphy C; Blum P; Woodward S; McCarthy K; Mathis D; Johnson C; Bedford P
    J Infect Dis; 2003 Oct; 188(8):1213-30. PubMed ID: 14551893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A special note on Japanese encephalitis vaccine.
    Lamabadusuriya SP
    Ceylon Med J; 1993 Sep; 38(3):103-4. PubMed ID: 7828224
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis.
    Guirakhoo F; Zhang ZX; Chambers TJ; Delagrave S; Arroyo J; Barrett AD; Monath TP
    Virology; 1999 May; 257(2):363-72. PubMed ID: 10329547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination with complete adjuvant-added inactivated virus vaccine of Japanese encephalitis to swine for preventing viremia (with specific reference to the effect of vaccination on viremia; epidemiological study on Japanese encephalitis. 35).
    Ogata M; Nagao Y; Jitsunari F; Kikui R; Kitamura N
    Acta Med Okayama (1952); 1970; 24(6):579-87. PubMed ID: 4334578
    [No Abstract]   [Full Text] [Related]  

  • 6. IC51 Japanese encephalitis vaccine.
    Kollaritsch H; Paulke-Korinek M; Dubischar-Kastner K
    Expert Opin Biol Ther; 2009 Jul; 9(7):921-31. PubMed ID: 19527110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reaction with mannan of a live Japanese encephalitis virus vaccine.
    Nozima T; Yasui K
    Acta Virol; 1971 Mar; 15(2):174. PubMed ID: 4396417
    [No Abstract]   [Full Text] [Related]  

  • 8. Potency testing of inactivated tissue culture vaccine against Japanese encephalitis using antigen capture ELISA.
    Joshi AM; Walimbe AM; Banerjee K
    Acta Virol; 1997 Jun; 41(3):157-9. PubMed ID: 9385404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of Japanese encephalitis vaccine in Henan, China: a case-control study.
    Luo D; Yin H; Xili L; Song J; Wang Z
    Southeast Asian J Trop Med Public Health; 1994 Dec; 25(4):643-6. PubMed ID: 7667706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Japanese encephalitis DNA vaccine candidates expressing premembrane and envelope genes induce virus-specific memory B cells and long-lasting antibodies in swine.
    Konishi E; Yamaoka M; Kurane I; Mason PW
    Virology; 2000 Mar; 268(1):49-55. PubMed ID: 10683326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National Advisory Committee on Immunization (NACI). Statement on Japanese encephalitis vaccine.
    Can Commun Dis Rep; 1993 Oct; 19(19):160-4. PubMed ID: 8251988
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of complete adjuvant on vaccination of live attenuated Japanese encephalitis vaccine to swine for preventing viremia. 39. Epidemiological studies of J.E.
    Ogata M; Nagao Y; Kikui R; Kitamura N; Ariyasu H
    Acta Med Okayama (1952); 1971; 25(1):71-5. PubMed ID: 4334469
    [No Abstract]   [Full Text] [Related]  

  • 13. [Analysis on the immuno-effects of two different Japanese encephalitis virus vaccines].
    Guo W; Li L; Wu Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 1998 Apr; 19(2):97-9. PubMed ID: 10322719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune response in mice infected with the attenuated Japanese encephalitis vaccine strain SA14-14-2.
    Lee T; Komiya T; Watanabe K; Aizawa C; Hashimoto H
    Acta Virol; 1995 Jun; 39(3):161-4. PubMed ID: 8578998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A large-scale study on the safety and epidemiological efficacy of Japanese encephalitis (JE) live vaccine (SA14-14-2) in the JE endemic areas].
    Zhou B; Jia L; Xu X
    Zhonghua Liu Xing Bing Xue Za Zhi; 1999 Feb; 20(1):38-41. PubMed ID: 10682513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Japanese encephalitis: development of new candidate vaccines.
    Bharati K; Vrati S
    Expert Rev Anti Infect Ther; 2006 Apr; 4(2):313-24. PubMed ID: 16597211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Japanese encephalitis and dengue vaccines.
    Barrett AD
    Biologicals; 1997 Mar; 25(1):27-34. PubMed ID: 9167006
    [No Abstract]   [Full Text] [Related]  

  • 18. Japanese encephalitis vaccination in Thailand.
    Fukunaga T; Rojanasuphot S; Wungkorbkiat S; Thammanichanon A; Kan T
    Biken J; 1974 Mar; 17(1):21-31. PubMed ID: 4368852
    [No Abstract]   [Full Text] [Related]  

  • 19. Intradermal boosting of Japanese encephalitis vaccination.
    Kitchener S; Baade L; Brennan L; Nasveld P
    J Travel Med; 2004; 11(3):182-3. PubMed ID: 15710061
    [No Abstract]   [Full Text] [Related]  

  • 20. Failure of Japanese encephalitis vaccine and infection in inducing neutralizing antibodies against West Nile virus, People's Republic of China.
    Tang F; Zhang JS; Liu W; Zhao QM; Zhang F; Wu XM; Yang H; Ly H; Cao WC
    Am J Trop Med Hyg; 2008 Jun; 78(6):999-1001. PubMed ID: 18541783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.